David Ilson, MD

Medical Oncologist

Conditions Treated

Lung Cancer

specialties & services

MRI

Bio & Insurance Information

Dr. David Ilson is a medical oncologist in who lives in New York and currently works at Memorial Sloan Kettering Cancer Center. He got his medical degree from New York University School of Medicine and completed an internship and a residency at Bellevue Hospital Center. He completed his studies with a fellowship at Memorial Sloan-Kettering Cancer Center. Dr. David Ilson is board certified in internal medicine and oncology with over 20 years of practice.


Education & Training

New York University School Of Medicine Graduated in 1986

Medical School

Bellevue Hospital Center Completed in 1987

Internship

Bellevue Hospital Center Completed in 1989

Residency

Meml Sloan-Kettering Hosp Completed in 1992

Fellowship

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine - Oncology

Hospitals & Clinics

Memorial Sloan Kettering Cancer Center

Languages: English/Spanish

(212) 639-2000

1275 York Ave

New York, New York 10065

Read More

Publications

Dr. David Ilson has contributed to 3 publications.

Esophageal and Esophagogastric Junction Cancers.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H;

See more >>

Recurrence and Survival After Pathologic Complete Response to Preoperative Therapy Followed by Surgery for Gastric or Gastrooesophageal Adenocarcinoma.

Fields RC1, Strong VE, Gönen M, Goodman KA, Rizk NP, Kelsen DP, Ilson DH, Tang LH, Brennan MF, Coit DG, Shah MA.

See more >>

Choroidal Metastases from Esophageal Adenocarcinoma Responding to Chemotherapy with Cisplatin and Irinotecan.

Morris PG1, Oda J, Heinemann MH, Ilson DH.

See more >>

Memberships

Cancer and Leukemia Group B

Radiation Therapy Oncology Group